Allogene Therapeutics, Inc. - Common Stock (ALLO)
CUSIP: 019770106
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 228,416,724
- Total 13F shares
- 86,172,174
- Share change
- +1,442,325
- Total reported value
- $2,214,699,254
- Put/Call ratio
- 193%
- Price per share
- $25.70
- Number of holders
- 165
- Value change
- +$36,168,155
- Number of buys
- 67
- Number of sells
- 82
Quarterly Holders Quick Answers
What is CUSIP 019770106?
CUSIP 019770106 identifies ALLO - Allogene Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 019770106:
Top shareholders of ALLO - Allogene Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. |
13F
|
Company |
8.2%
|
18,716,306
|
$488,121,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.1%
|
7,021,939
|
$183,132,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
6,602,306
|
$172,189,000 | — | 30 Jun 2021 | |
| Capital Research Global Investors |
13F
|
Company |
2.4%
|
5,404,300
|
$140,944,000 | — | 30 Jun 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.6%
|
3,577,030
|
$93,289,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
3,535,184
|
$92,198,000 | — | 30 Jun 2021 | |
| Capital International Investors |
13F
|
Company |
1.5%
|
3,525,114
|
$91,935,000 | — | 30 Jun 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.4%
|
3,166,630
|
$82,586,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
3,004,900
|
$78,368,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
2,484,735
|
$64,802,000 | — | 30 Jun 2021 | |
| Capital World Investors |
13F
|
Company |
0.98%
|
2,246,577
|
$58,591,000 | — | 30 Jun 2021 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
0.79%
|
1,798,163
|
$46,896,000 | — | 30 Jun 2021 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
0.75%
|
1,716,370
|
$44,763,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.75%
|
1,715,387
|
$44,737,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.69%
|
1,570,629
|
$40,962,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
1,228,081
|
$32,028,000 | — | 30 Jun 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
0.54%
|
1,225,000
|
$31,948,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.49%
|
1,129,478
|
$29,456,000 | — | 30 Jun 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.35%
|
800,000
|
$20,864,000 | — | 30 Jun 2021 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
0.34%
|
773,562
|
$20,174,000 | — | 30 Jun 2021 | |
| Sessa Capital IM, L.P. |
13F
|
Company |
0.33%
|
750,000
|
$19,560,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
735,094
|
$19,172,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.31%
|
704,400
|
$18,371,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.3%
|
684,755
|
$17,858,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
0.29%
|
663,849
|
$17,313,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
634,369
|
$16,545,000 | — | 30 Jun 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.27%
|
606,800
|
$15,825,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.25%
|
573,604
|
$14,960,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
505,295
|
$13,178,000 | — | 30 Jun 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.2%
|
456,591
|
$11,908,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
410,810
|
$10,714,000 | — | 30 Jun 2021 | |
| Cerity Partners LLC |
13F
|
Company |
0.18%
|
400,152
|
$10,436,000 | — | 30 Jun 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.17%
|
398,180
|
$10,384,535 | — | 30 Jun 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.14%
|
325,040
|
$8,477,000 | — | 30 Jun 2021 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.14%
|
311,306
|
$8,119,000 | — | 30 Jun 2021 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.13%
|
303,240
|
$7,908,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
282,336
|
$7,363,000 | — | 30 Jun 2021 | |
| Pier Capital, LLC |
13F
|
Company |
0.12%
|
278,828
|
$7,272,000 | — | 30 Jun 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.12%
|
275,000
|
$7,172,000 | — | 30 Jun 2021 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.1%
|
237,155
|
$6,185,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
233,783
|
$6,097,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.09%
|
202,263
|
$5,275,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.09%
|
198,288
|
$5,171,000 | — | 30 Jun 2021 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.08%
|
173,454
|
$4,524,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
170,500
|
$4,447,000 | — | 30 Jun 2021 | |
| PDT Partners, LLC |
13F
|
Company |
0.07%
|
163,828
|
$4,273,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
163,099
|
$4,253,000 | — | 30 Jun 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.06%
|
148,329
|
$3,868,000 | — | 30 Jun 2021 | |
| DSAM Partners (London) Ltd |
13F
|
Company |
0.06%
|
144,000
|
$3,756,000 | — | 30 Jun 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.06%
|
141,935
|
$3,701,000 | — | 30 Jun 2021 |
Institutional Holders of Allogene Therapeutics, Inc. - Common Stock (ALLO) as of Q3 2021
As of 30 Sep 2021,
Allogene Therapeutics, Inc. - Common Stock (ALLO) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,172,174 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., BlackRock Inc., VANGUARD GROUP INC, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, Capital International Investors, STATE STREET CORP, JPMORGAN CHASE & CO, and ALLIANCEBERNSTEIN L.P..
This page lists
165
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
175
Q3 2021 holders
165
Holder diff
-10
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.